# Phase 3 Closeout Evidence

Recorded: 2026-08-13

Phase status: **COMPLETE / FOUNDER_APPROVED**

## Acceptance conclusion

Phase 3's objective—one coherent and verified clinical visit workflow across discharge preparation, lifecycle transitions, record completion, checkout handoff, and operational views—is satisfied. The founder approved Phase 3 after its authoritative verification and latest independent Claude review passed.

## Verification and review evidence

- The authoritative Phase 3 verification is [`runs/2026-08-14T00-44-08-144Z/verification-2.md`](./runs/2026-08-14T00-44-08-144Z/verification-2.md). The associated run records `verificationState: "PASS"`.
- Typecheck, unit tests, build, and integration passed; integration recorded 192 of 192 tests passing.
- Lint reproduced only the exact approved Phase 4 inventory debt and was classified `COMPLETE_WITH_KNOWN_DEBT`.
- Playwright reproduced the exact approved baseline of 24 failed, 1 did not run, and 5 passed, with no new, missing, or materially changed failure identities, and was classified `COMPLETE_WITH_KNOWN_DEBT`.
- The latest independent Claude review is [`runs/2026-08-14T01-18-05-494Z/review-1.md`](./runs/2026-08-14T01-18-05-494Z/review-1.md) and is recorded as **PASS**. Its run-local `verificationState: "NOT_RUN"` does not supersede the authoritative verification evidence above.

## Preserved artifacts

All Phase 3 planning, implementation, remediation, verification, review, founder-decision, and run-state artifacts remain unchanged. This closeout records the founder decision in durable project memory without rewriting historical run state, rerunning verification, or executing the orchestration workflow.

## Non-blocking follow-up notes

- Optional direct Today-view lifecycle coverage remains a low-severity hardening opportunity. Current coverage verifies the shared dashboard payload used by Today, so this does not block Phase 3 acceptance.
- The prior placeholder review artifact at `runs/2026-08-14T00-44-08-144Z/review-2.json` remains preserved as an orchestration observation only. It is not treated as a substantive review verdict and requires no Phase 3 remediation.

Neither note is remediated as part of this closeout.

## Handoff

Phase 3 is complete and founder-approved. Phase 4 — Inventory Integrity Hardening is the next approved and active phase. No Phase 4 implementation, verification, product behavior change, or `sparki:execute` run is part of this closeout.
